JDRF - Juvenile Diabetes Research Foundation

Scientists believe they may have found a preventative therapy for type 1 diabetes that makes the body tolerate the insulin-producing cells that would normally be attacked and destroyed at disease onset.

PhD student Eliana Mariño and Dr Shane Grey, from the Garvan Institute of Medical Research in Sydney, have demonstrated how a particular molecule may be used to prevent type 1 diabetes in the future. Their findings are published online in the international journal Diabetes.

JDRF’s Research Development Manager said this research, part funded by JDRF, is significant. “These results are impressive and they represent a promising step towards a vaccine for type 1 diabetes.”

Read more...

The Juvenile Diabetes Research Foundation (JDRF) is proud to award Boral with the 2008 Freedom Award, recognizing the greatest contribution to fundraising programs from a single supporter.

Boral’s combined staff and corporate donations of nearly $450,000 in 2008 have been invested into the best Australian medical research programs that seek a cure for type 1 diabetes and its complications.

The 2008 Freedom Award caps a productive eight year partnership that has seen Boral reach an extraordinary $2 million in contributions to JDRF.

Read more...